Equity Profile

CC

The Chemours Company

MaterialsDiversified Chemicals$2.3B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Chemours Company (CC) is a global leader in the diversified chemicals sector, specializing in titanium technologies, fluoroproducts, and chemical solutions. As a key player in materials, its performance is closely tied to trends in industrial demand and environmental regulations.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and reflects the company's ability to generate earnings for shareholders.

$0.42

Revenue

Revenue indicates the overall sales performance and demand for Chemours' products, which is essential for assessing growth.

$1.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q1-2026, Chemours reported an EPS of $0.05, significantly beating expectations by 194%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Focus on cost management and operational efficiency.
Commitment to sustainability initiatives.
Plans to enhance product offerings in fluoroproducts.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Chemours' upcoming earnings, expecting a modest EPS of $0.42 and revenue of $1.7 billion. The company's recent performance suggests potential for positive surprises.

Bull Case

If Chemours can leverage its cost management strategies effectively, it may exceed EPS expectations and show strong revenue growth, reflecting robust demand.

Bear Case

On the other hand, if the company faces challenges in maintaining margins or if demand weakens, it could miss expectations, leading to a negative market reaction.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.42

EPS is a critical measure of profitability and reflects the company's ability to generate earnings for shareholders.

Revenue

$1.7B

Revenue indicates the overall sales performance and demand for Chemours' products, which is essential for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve an EPS of $0.42 or higher?

This figure is crucial for investor confidence and reflects the company's profitability amid cost pressures.

What are the revenue figures and growth outlook for the fluoroproducts segment?

Fluoroproducts are a key area for Chemours, and strong performance here could indicate overall business health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Chemours' ability to manage costs effectively, leading to better-than-expected margins despite revenue challenges.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% beat rate in recent quarters.

Options pricing indicates a significant expected move, suggesting that traders anticipate volatility and potential surprises.

Recent operational improvements may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS significantly above $0.42, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report will clarify whether Chemours can maintain its profitability and growth trajectory in a challenging market.

Bull Confirmed If

An EPS of $0.50 or better would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.30 would raise concerns about profitability and market conditions.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.5% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +3.23%, confirming positive market sentiment.

In-Line / Cautious

An in-line report may lead to a muted reaction, as investors await further clarity on future guidance.

Miss

If the company misses expectations, history suggests a potential decline of about -1.78%, reflecting disappointment in performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on cost management strategies and their impact on margins.
2Updates on demand trends in the fluoroproducts segment.
3Any commentary on sustainability initiatives and their market reception.
4Insights into competitive positioning within the diversified chemicals sector.
5Management's outlook on macroeconomic factors affecting the business.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and reflects the company's ability to generate earnings for shareholders.

$0.42

Revenue

Revenue indicates the overall sales performance and demand for Chemours' products, which is essential for assessing growth.

$1.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q1-2026, Chemours reported an EPS of $0.05, significantly beating expectations by 194%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Focus on cost management and operational efficiency.
Commitment to sustainability initiatives.
Plans to enhance product offerings in fluoroproducts.

Expectations

Wall Street Expectations

Bull Case

If Chemours can leverage its cost management strategies effectively, it may exceed EPS expectations and show strong revenue growth, reflecting robust demand.

Bear Case

On the other hand, if the company faces challenges in maintaining margins or if demand weakens, it could miss expectations, leading to a negative market reaction.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.42

EPS is a critical measure of profitability and reflects the company's ability to generate earnings for shareholders.

Revenue

$1.7B

Revenue indicates the overall sales performance and demand for Chemours' products, which is essential for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve an EPS of $0.42 or higher?

This figure is crucial for investor confidence and reflects the company's profitability amid cost pressures.

What are the revenue figures and growth outlook for the fluoroproducts segment?

Fluoroproducts are a key area for Chemours, and strong performance here could indicate overall business health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Chemours' ability to manage costs effectively, leading to better-than-expected margins despite revenue challenges.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% beat rate in recent quarters.

Options pricing indicates a significant expected move, suggesting that traders anticipate volatility and potential surprises.

Recent operational improvements may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS significantly above $0.42, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The upcoming earnings report will clarify whether Chemours can maintain its profitability and growth trajectory in a challenging market.

Bull Confirmed If

An EPS of $0.50 or better would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.30 would raise concerns about profitability and market conditions.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.5% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +3.23%, confirming positive market sentiment.

In-Line / Cautious

An in-line report may lead to a muted reaction, as investors await further clarity on future guidance.

Miss

If the company misses expectations, history suggests a potential decline of about -1.78%, reflecting disappointment in performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on cost management strategies and their impact on margins.
2Updates on demand trends in the fluoroproducts segment.
3Any commentary on sustainability initiatives and their market reception.
4Insights into competitive positioning within the diversified chemicals sector.
5Management's outlook on macroeconomic factors affecting the business.